FDA Approves GMO Hemp Rich in CBG

1w
2m read
Summary

This initiative, backed by state-level marijuana legalization and federal acceptance of low-THC hemp products, aims to significantly intensify research interest in the hemp industry. This genetically modified variant, developed to have higher levels of the cannabinoid CBG and without the psychoactive components THC or CBD, could revolutionize the hemp industry. The hemp consortium initiative also indicates a promising future for collaboration among industry stakeholders along the entire supply chain. Another suggestion involves eliminating restrictions on industry engagement for people with previous drug convictions.The Current Challenges of the Hemp IndustryDespite these advancements, the hemp sector continues encountering regulatory obstacles that have impacted its value since legalization. By bringing together industry stakeholders, the consortium could pave the way for innovative collaborations and advancements in the sector.Federal Lawmakers Weigh In On Hemp RegulationsFederal lawmakers are urged to modify the definition of hemp to clarify regulations surrounding its derivative products.

Article Preview

The recent approval by the United States Department of Agriculture (USDA) of a genetically modified variant of hemp, known as “Badger G,” is a significant milestone for the industry.

Developed by researchers in Wisconsin, this strain, unlike traditional hemp, does not contain THC or CBD. Instead, it is engineered to have higher levels of the cannabinoid CBG.

The USDA’s Animal and Plant Health Inspection Service has confirmed that Badger G and five other unrelated genetically engineered plant varieties are not subject to regulation under 7 CFR part 340, which oversees the movement of genetically...

Read the full article @ Marijuana Index